SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: HiSpeed who wrote (4741)8/5/1998 3:48:00 AM
From: Anthony Wong  Respond to of 9523
 
Russian experts ponder: Do our men need Viagra?

By Adam Tanner

MOSCOW, Aug 4 (Reuters) - Russian men will be among the
first outside the United States able to buy the impotence drug
Viagra legally starting in October -- but it's unclear how many
will actually want it, officials said on Tuesday.

With 58 the average age of death for Russian males, much of
Viagra's prime potential market is eliminated. But experts say
middle-aged Russian men suffer from the same sexual problems as
those elsewhere -- although they may be more reluctant to
acknowledge them.

"The level of sexual disorders is very high in Russia,"
Tatyana Agarkova, a doctor and member of the Culture and Health
Sexology Association, said in an interview. "Russia is not
different from other countries in needing help."

Smoking, alcoholism, stress, poor eating habits and other
banes of Russian contemporary life can contribute to impotence
-- but these lifestyle factors have also sharply lowered Russian
men's life expectancy.

At a news conference to present the drug, sensitivity over
any threat to the perceived virility of Russian men sometimes
overcame scientific analysis.

"The percentage of impotent men in Russia is far lower than
in America," said an agitated Nikolai Lopatkin, 74, director of
the Russian Institute for Urology, who wore a Soviet-era "Hero
of Socialist Labour" gold star on his lapel. "Don't think that
half of our men are impotent, it's far from the case."

Robert Marshall, head of the Russia office for U.S. drugs
firm Pfizer PFE.N which makes Viagra, said a company study
concluded that about four million Russian men above the age of
35 -- 14 percent of the total -- suffered from impotency and
were potential customers.

But he said it was unclear whether they would seek medical
help and whether they could afford the average cost of $12 for a
single tablet which Pfizer plans on charging in Russia.

"The potential for Viagra is very hard to estimate," he
said.

Many Russian pensioners, who under the Soviet Union rarely
discussed sexual problems in public, saw their savings wiped out
in the hyper-inflation of the early 1990s after the collapse of
Communism.

So far there are no plans to subsidise Viagra costs for the
needy, said Galina Koslesnikova, head of the Health Ministry's
drug registration division.

Viagra is already available on the Russian black market at
prices ranging from about $14 to $250 a pill, medical experts
say. Sometimes blackmarket dealers even proffer fakes such as a
strong laxative.

"As soon as it appeared in the United States it came to the
Russian black market," said Agarkova, who hailed the drug's
legal arrival.

"Selling it through such illegal channels outside the
control of doctors is extraordinarily dangerous."

As in the United States, Switzerland, Canada and Brazil
where it is already sold, Russia will offer Viagra only by
prescription after its official introduction in October.

Experts said some Russians, including the new rich wanting
to see if they can enhance sexual performance, will continue to
seek Viagra through non-official channels.

"Our main concern is that patients will be taking Viagra
either who don't need it or without any information about it,"
said Pfizer's Marshall.

He added that in the United States about two million men in
the United States had taken Viagra since its April introduction,
with Pfizer selling 25 million tablets there.

REUTERS
Rtr 13:25 08-04-98

Copyright 1998, Reuters News Service

dljdirect.com